Business
Perimeter Announces Closing of Final Tranche of Prospectus Offering for $2.25 Million; Total Gross Proceeds of $5.35 Million Raised Under Prospectus Offering
Perimeter Announces Closing of Final Tranche of Prospectus Offering for $2.25 Million; Total Gros...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\n\n Perimeter Announces Closing of Final Tranche of Prospectus Offering for $2.25 Million; Total Gross Proceeds of $5.35 Million Raised Under Prospectus Offering\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n\n\n\n\n\n\n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n\n\n\n\n TORONTO\n \n and\n \n DALLAS\n \n\n ,\n \n\n July 29, 2025\n \n\n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (\"\n \n Perimeter\n \n \" or the \"\n \n Company\n \n \"), a commercial-stage medical technology company, is pleased to announce that it has closed the second tranche of its previously announced prospectus offering (the \"\n \n Offering\n \n \") of units of the Company (the \"\n \n Units\n \n \") and pre-funded units of the Company. The Offering was completed on a reasonable \"best efforts\" agency basis pursuant to an agency agreement (the \"\n \n Agency Agreement\n \n \") dated\n \n May 29, 2025\n \n between the Company and A.G.P. Canada Investments ULC (the \"\n \n Agent\n \n \"). Pursuant to the Offering, the Company has issued an aggregate of 7,416,667 Units at a price of\n \n $0.30\n \n per Unit for aggregate gross proceeds of approximately\n \n $2,225,000\n \n . Inclusive of the closing of the initial tranche, the Company has issued an aggregate of 17,849,468 Units pursuant to the Offering, for aggregate gross proceeds of approximately\n \n $5,354,840\n \n . The Company does not expect to close any further tranches of the Offering.\n \n\n Each Unit is comprised of one common share in the capital of the Company (each a \"\n \n Common Share\n \n \") and one Common Share purchase warrant (each a \"\n \n Warrant\n \n \"). Each Warrant entitles the holder to acquire an additional Common Share for a period of 60 months, at an exercise price of\n \n $0.35\n \n .\n \n\n In connection with the second tranche closing of the Offering, the Company paid the Agent a cash commission equal to 3.5% of the proceeds of the Offering attributab...